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Abstract
Coxiella burnetii, the causative agent of human Q fever, is an intracellular pathogen that replicates in an acidified vacuole derived
from the host lysosomal network. This pathogen encodes a Dot/Icm type IV secretion system that delivers bacterial proteins
called effectors to the host cytosol. To identify new effector proteins, the functionally analogous Legionella pneumophila Dot/Icm
system was used in a genetic screen to identify fragments of C. burnetii genomic DNA that when fused to an adenylate cyclase
reporter were capable of directing Dot/Icm-dependent translocation of the fusion protein intomammalian host cells. This screen
identified Dot/Icm effectors that were proteins unique to C. burnetii, having no overall sequence homology with L. pneumophila
Dot/Icm effectors. A comparison of C. burnetii genome sequences from different isolates revealed diversity in the size and
distribution of the genes encoding many of these effectors. Studies examining the localization and function of effectors in
eukaryotic cells provided evidence that several of these proteins have an affinity for specific host organelles and can disrupt
cellular functions. The identification of a transposon insertion mutation that disrupts the dot/icm locus was used to validate that
this apparatus was essential for translocation of effectors. Importantly, this C. burnetii Dot/Icm-deficient mutant was found to be
defective for intracellular replication. Thus, these data indicate that C. burnetii encodes a unique subset of bacterial effector
proteins translocated into host cells by the Dot/Icm apparatus, and that the cumulative activities exerted by these effectors
enables C. burnetii to successfully establish a niche inside mammalian cells that supports intracellular replication.
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Introduction
Coxiella burnetii, a Gram-negative facultative intracellular bacte-
rium, is the causative agent of human Q fever, a worldwide
zoonosis predominantly linked to exposure to domesticated
livestock. Q fever typically manifests as an acute flu-like illness,
however, chronic Q fever can also develop, typically in
immunocompromised individuals [1].
Fundamental to the pathogenesis of C. burnetii is the capacity to
replicate within a specialized vacuole that is derived from host
lysosomes. C. burnetii requires the low pH environment of the
lysosome to convert from the environmentally-resistant small cell
variant that is the infectious form of the bacterium to a large cell
variant that represents the replicative form of the bacterium [2,3].
The Coxiella-containing vacuole (CCV) retains the degradative
capacity of a lysosome [4], and is decorated by the host lipid raft
proteins flotilin 1 and 2 and the autophagosome marker LC3
[5,6]. The CCV also undergoes expansion, often occupying the
majority of the host cytoplasm, through robust homotypic fusion
with endolysosomal vesicles [7]. Importantly, the formation and
development of this fusogenic CCV is dependent on bacterial
protein synthesis [7], implying that C. burnetii directs formation of
the vacuole in which it resides.
C. burnetii proteins important for establishment of this specialized
vacuole are predicted to be translocated into the cytosol of the host
cell by the Dot/Icm type IV secretion system. This secretion system
has both sequence homology and functional similarity to the Dot/
Icm apparatus of Legionella pneumophila [8–10], which is involved in
manipulating cellular functions in the protozoan hosts that L.
pneumophila has coevolved with in nature [11], and also in
mammalian cells that represent accidental hosts for this bacterium
[12–14]. Within these evolutionarily diverse phagocytic host cells,
the L. pneumophila Dot/Icm system is essential for establishment of a
unique endoplasmic reticulum-derived vacuole that enables intra-
cellular survival and replication of this pathogen [15–17]. It is
estimated that L. pneumophila is capable of translocating over 200
different proteins using the Dot/Icm system [18,19]. Loss of a single
effector protein in L. pneumophila does not typically diminish
intracellular replication, indicating a degree of functional redundan-
cy among the effectors that is not resolved through standard
approachesinvolvingforwardgeneticanalysis.Definedaspectsofthe
L.pneumophilavacuolemorphology,however,canbelinkedtospecific
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has a specific role in manipulating the function of the host GTPase
Rab1 and promoting the localization of Rab1 to vacuoles containing
L. pneumophila [20–22]. Similarly, the effector RalF recruits the host
GTPase Arf1 to vacuoles, and ralF mutant bacteria occupy vacuoles
that fail to recruit Arf1 to their limiting membrane [23].
Although proteins that have limited regions of homology with L.
pneumophila effectors are encoded by C. burnetii,t h i si n t r a c e l l u l a r
pathogen does not appear to produce bone fide homologues of L.
pneumophila Dot/Icm effector proteins. This suggests that these
pathogens possess unique effector repertoires that could reflect the
divergent pathways that have resulted in these organisms occupying
unique replicative niches within evolutionarily diverse eukaryotic
hosts. L. pneumophilawas used previouslyas a surrogate to demonstrate
several C. burnetii Ank proteins containing ankyrin repeat homology
domains are translocated into mammalian hosts by a Dot/Icm-
dependent mechanism [24,25]. Comparative genomics revealed a
highdegreeofvariationoftheseAnkproteinsamongdifferentisolates
of C. burnetii, with mutations rendering many Ank coding regions as
putative pseudogenes [25]. One of the few Ank proteins conserved
among the sequenced C. burnetii isolates is AnkG, which has been
demonstrated to mediate potent anti-apoptotic activity when
translocated into mammalian host cells by the Dot/Icm system
[26]. Given the diverse repertoire of Dot/Icm effectors encoded by
L. pneumophila, there should be many novel effectors encoded by
C. burnetii in addition to the Ank proteins.
The goal of this study was to identify new effectors from C.
burnetii by conducting an unbiased screen for type IV secretion
signals capable of delivering the calmodulin-dependent adenylate
cyclase protein into host cells by the Dot/Icm system, and
determine whether the delivery of effectors by C. burnetii is
important for host cell infection.
Results
A screen for type IV translocation signals identifies novel
C. burnetii effectors
Most Dot/Icm effectors contain a translocation signal recog-
nized by the type IV apparatus, which is typically located near the
carboxyl terminal region of the protein [18,25,27]. Thus, an
unbiased genetic screen was designed to identify C. burnetii proteins
having Dot/Icm-dependent translocation signals. A library was
constructed by inserting random fragments of genomic DNA from
C. burnetii RSA493 Nine Mile phase II (NM) downstream of a
plasmid-encoded adenylate cyclase (Cya) enzyme that would serve
as a reporter for translocation of proteins into the cytosol of host
cells by the Dot/Icm system. The C. burnetii genomic DNA
fragments were generated by limited digestion with the restriction
enzyme SauIIIA1 and ligation of the resulting DNA fragments
downstream of a cya reporter in the plasmid pEC33. The resulting
plasmid library was introduced into L. pneumophila to screen for C.
burnetii genes containing a type IV translocation signal that when
fused in frame with cya would result in a hybrid protein delivered
into mammalian host cells by the Dot/Icm system.
Because the possibility of a single plasmid in the library having a
DNA fragment inserted in the correct orientation and in frame
with cya was predicted to be roughly one in six, the decision was
made to screen a pool of bacteria containing different plasmid
clones rather than initially screening individual clones from the
library. To determine the feasibility of identifying a single
translocated effector in pools of transformants, L. pneumophila
expressing Cya-RalF, a fusion protein known to be efficiently
translocated by the Dot/Icm system [23,27], and L. pneumophila
producing Cya alone, were mixed at defined ratios. Infection at a
ratio of bacteria producing Cya-RalF to bacteria producing the
control Cya of 1:50 reproducibly led to an increase in host cell
cAMP levels of at least 2.5-fold over background levels (Figure S1).
These data indicated that it should be possible to detect a single
positive clone with a type IV-dependent translocation signal fused
to Cya in a mixed pool containing roughly 50 negative clones.
Thus, the library of clones was distributed into pools that
contained an estimated 50 different transformants harboring a
randomly inserted C. burnetii gene downstream of cya (Figure S2).
Mammalian CHO FccRII cells [28] were infected with the pools
of L. pneumophila containing Cya fused randomly to C. burnetii gene
products. Screening identified pools that resulted in a significant
increase in host cAMP levels above background, and these pools
were further analyzed to isolate individual clones with an in-frame
fusion between cya and a C. burnetii gene having a functional Dot/
Icm translocation signal.
A total of 22-positive clones were identified from the 506
different pools tested in the translocation assay, which would
theoretically represent the screening of 4200 in-frame fusions.
Plasmids were isolated from the positive clones and DNA
sequencing was used to identify the predicted C. burnetii pro-
tein fused to Cya. This analysis resulted in the identification of
11 potential Dot/Icm effector proteins (Table S1), including
the previously characterized Dot/Icm effector AnkG (CBU0781)
[24–26].
To validate that the proteins identified in the screen were bone
fide type IV effectors, the predicted full-length open reading frames
for each of the 10 new proteins identified in the screen were
amplified using genomic DNA from the C. burnetii NM strain, and
the resulting full-length NM gene was fused to the C-terminus of
Cya. Plasmids encoding a putative full-length effector fused to Cya
were introduced into a strain of L. pneumophila having a functional
Dot/Icm system and a DdotA mutant strain with a non-functional
type IV apparatus [15]. Seven of the 10 C. burnetii fusion proteins
showed significant increases in cAMP levels compared to controls
(Figure 1A). Importantly, translocation was observed to be
dependent upon a functional Dot/Icm system as cAMP levels
were unchanged after infection with the DdotA strain (Figure 1A).
The three fusion proteins that did not demonstrate translocation;
Author Summary
Coxiella burnetii is a Gram-negative intracellular bacterium
that can cause the human disease Q fever. A type IV
secretion system in C. burnetii called Dot/Icm is function-
ally similar to the Dot/Icm system of Legionella pneumo-
phila. Here we used L. pneumophila to screen a C. burnetii
library for genes encoding effector proteins. We identified
18 effectors that are unique to C. burnetii and show that
when they are expressed in eukaryotic cells they localize to
specific compartments and can mediate changes in host
cell physiology. Comparative genomic analysis revealed
plasticity among these novel effector proteins that could
be related to the different manifestations of disease
exhibited by these clinical isolates of C. burnetii.A
transposon insertion mutation in the dot/icm locus
revealed for the first time that type IV secretion is essential
for C. burnetii replication inside mammalian host cells and
that the delivery of effectors requires Dot/Icm function.
Thus, this study conclusively shows that the C. burnetii
Dot/Icm system is an essential determinant for intracellular
replication, and identifies a repertoire of unique effector
proteins with novel functions delivered by this system that
could be important for disease phenotypes.
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comparable to Cya and Cya-RalF in L. pneumophila (Figure S3).
Because genes encoding L. pneumophila effectors are often found in
clusters at distinct chromosomal locations and can be duplicated to
generate families of paralogous effectors [29], we investigated
whether any of the C. burnetii genes in close proximity or with
extensive sequence similarity to the identified effectors might also
encode effectors. Thirty-seven additional C. burnetii genes that fit
these criteria were tested for translocation by L. pneumophila (Table
S2). Of the 37 genes tested, there were 11 genes encoding proteins
translocated into host cells by a Dot/Icm-dependent mechanism
(Figure 1B). Thus, this screen in total resulted in the identification of
18 different C. burnetii proteins that are effectors delivered into host
cells by the L. pneumophila Dot/Icm apparatus.
Genomic comparisons indicate plasticity among novel C.
burnetii effectors
Sequence analysis revealed that none of the 18 C. burnetii Dot/
Icm effectors have significant homology to proteins found in other
organisms, demonstrating the unique nature of these proteins.
CBU0077 from the strain NM RSA493 is highly conserved in the
two different sequenced C. burnetii strains isolated from chronic Q-
fever patients presenting with endocarditis (G Q212 and K Q154)
and in the Dugway strain isolated from rodents [30], which does
not appear to cause clinical disease. For the remaining effectors,
there were polymorphisms in the coding regions that would
indicate that these effectors have either been mutated or have not
been acquired by one or more of the strains of C. burnetii.A n
alignment of these effectors in all sequenced strains is presented in
Figure 2. A comparison of the NM genome to the genomes of the
G, K and Dugway strains revealed nucleotide deletions or
nonsense mutations in the NM genes that would predict the
production of a shorter version of several effector proteins
compared to homologues found in some of these other sequenced
strains [31]. Interestingly, three of the NM effectors identified
here, CBU1108, CBU1107 and CBU1776, are not present in the
G Q212 strain (Figure 2). Thus, similar to Dot/Icm effectors in L.
pneumophila, there is significant plasticity observed in the repertoire
of effectors of C. burnetii when genomes from different isolates are
compared [32]. Despite these polymorphisms, all of the genes
encoding the NM Dot/Icm effectors identified here were
transcribed during infection (Figure S4). Thus, the genes encoding
truncated NM effectors are transcribed and the predicted
translated products should be delivered into host cells during
infection by the functional Dot/Icm translocation signal identified
in the protein.
Structural features and host cell localization phenotypes
exhibited by C. burnetii effectors
Analysis of the C. burnetii effectors using the Simple Modular
Architecture Research Tool (SMART) database [33] revealed
domains in these proteins that could provide insight into potential
functions (Figure 2). Identified features included predicted
transmembrane domains (CBU0077/CBUD2029/CbuG1938/
CbuK1977, CBU0635/CBUD0646/CbuG1369/CbuK1621, and
CBUD0454/CbuG0477/CbuK1760), proteins with predicted
coiled-coil regions (CBU1524/CBUD0462/CbuG0486/CbuK1751,
CBUD0454/CbuG0477/CbuK1760, and CBU2052/CBUD2147/
CbuG2057/CbuK2099), an effector with three Sel1-like repeats
(SLRs; CBU0295/CBUD1787/CbuG1711) and a protein with a
helix-loop-helix motif (CbuG1937/CbuK1976). SLR-containing pro-
teins, found in eukaryotes and bacteria, are thought to mediate protein-
protein interactions and have been found in several pathogenic
b a c t e r i a .O fn o t e ,t w oo ft h eL. pneumophila SLR-containing proteins,
EnhC and LpnE, have been associated with virulence [34–36].
To further characterize the identified Dot/Icm effectors, the
products encoded by the NM genes and the longer derivatives
encoded by the Dugway, G or K strains, were ectopically
produced in HeLa 229 cells as proteins containing three tandem
copies of the N-terminal FLAG epitope tag. All of the NM
effectors demonstrated similar localization profiles as the homol-
ogous proteins isolated from the other C. burnetii strains, with the
exception of CBU0080. The NM CBU0080 protein showed
Figure 1. Dot/Icm-dependent translocation of C. burnetii pro-
teins by L. pneumophila. CHO-FccRII cells were infected with Dot/Icm-
sufficient LP01 strain of L. pneumophila (black) or the isogenic DdotA
mutant (grey) expressing Cya fusions to the indicated C. burnetii proteins.
(A)Fusions toCyaoftheindicated full-length derivativesof C.burnetiiNM
proteins identified in the genetic screen were tested for translocation (B).
Fusions to Cya of the indicated full-length derivatives of C. burnetii NM
proteinsidentifiedbasedonhomologyorproximitytoproteinsidentified
in the screen were tested for translocation. Cya indicates empty vector
control. Cya-RalF was used as a positive control. After 1 h, host cells were
lysed and cAMP was extracted. Total cAMP levels resulting from
translocation of protein fusions were quantified using an enzyme-
immunoassay system, and are shown in fmol. Results represent average
values +/2 SD of experiments performed in triplicate.
doi:10.1371/journal.ppat.1002056.g001
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PLoS Pathogens | www.plospathogens.org 3 May 2011 | Volume 7 | Issue 5 | e1002056Figure 2. Domain analysis and genomic comparisons for C. burnetii effectors identified in this study. The schematic shows the eighteen
NM effectors identified in this study represented in blue. Below each NM effector is a representation of the size of the homologous reading frame
encoded by the genes in the other sequenced strains of C. burnetii. The size of the predicted proteins is represented in kDa in brackets following the
gene designation. Black lines represent the presence of homologous DNA that does not encode an open reading frame due to small deletions
(vertical black line) and stop codons (red cross). In cases where multiple deletions occur the first deletion, representing the site of the frameshift, is
displayed. The locations of conserved domains in each protein identified in a SMART database search are indicated according to the key provided.
doi:10.1371/journal.ppat.1002056.g002
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which localized to the nucleus (Figure 3A). The N-terminal
19.4 kDa region in CbuK1976 that is absent in CBU0080 encodes
a predicted nuclear localization signal (NLS) containing the
peptide KKRK in addition to a helix-loop-helix motif.
Most of the proteins localized to the host cell cytosol or diffusely
throughout the cell when expressed in HeLa 229 cells (Table 1 and
Figure S5). Several proteins showed enrichment in specific
subcellular compartments as determined by colocalization with
proteins that label these host organelles. Similar to CbuK1976, the
CBU1524 protein localized to the nucleus when produced in
mammalian cells (Figure 3A). Nuclear localization of CBU1524
may be mediated by a predicted seven residue NLS containing the
peptide PKRTRVD that begins at amino acid position 182 in the
protein. The protein CBU0077 resided primarily on lysosomes as
demonstrated by colocalization with lysosomal-associated mem-
brane protein 1 (LAMP1). The protein CBU0635 was present
at a perinuclear position juxtaposed to the Golgi apparatus
(Figure 3B). Two NM effector proteins, CBU1532 and CBU1825,
along with the respective homologues from Dugway, CBUD0454
and CBUD0054, showed a specific affinity for mitochondria
(Figure 3C). No defined mitochondrial targeting sequences were
apparent in any of these effector proteins. Interestingly, CBU1532
appeared to affect the morphology of HeLa 229 cells, with many
transfected cells having a rounded appearance with aggregated
mitochondria. The Dugway protein, CBUD0454, did not mediate
this morphological change when expressed in HeLa 229 cells,
which might indicate that CBU1532 confers a dominant-negative
effect that perturbs cellular functions modulated by CBUD0454.
Similar localization patterns were observed in CHO-FccRII cells
and HEK 293 cells (data not shown), indicating that protein
localization patterns are not cell-type specific.
CBU0635 overproduction interferes with the host
secretory pathway
Several L. pneumophila Dot/Icm effectors have been shown to
disrupt vesicle trafficking in mammalian cells by affecting the
dynamics of membrane transport in the early secretory pathway
[20,21,23,24]. To investigate if any of the identified C. burnetii
proteins have effector functions that interfere with the secretory
pathway in mammalian cells, transport of secreted alkaline
phosphatase (SEAP) was investigated in HEK 293 cells ectopically
Figure 3. Effectors of C. burnetii show differential localization patterns when expressed in mammalian HeLa 229 cells.
Immunofluorescence micrographs show the representative localization profiles of the indicated FLAG-tagged C. burnetii effectors (Green) and the
indicated host organelles (Red) after ectopic production of the proteins in HeLa 229 cells. (A) CbuK1976 and CBU1524 show localization to the
nucleus, but the NM protein CBU0080 is distributed throughout the cytoplasm. The schematic shows that CBU0080 does not contain the helix-loop-
helix motif (octagon) found in the homolog CbuK1976, which could explain the differential localization phenotypes observed (B) Cells stained for
FLAG-tagged CBU0077 and LAMP1 show colocalization of the effector on lysosome-derived organelles, and cells stained for CBU0635 and GM130
show distribution of the protein to a perinuclear region containing the Golgi apparatus. (C). Cells stained for FLAG-tagged effectors and the TOM22
protein show colocalization of the effectors on mitochondria. The NM protein CBU1825 and the homologous Dugway protein CBUD0054 showed
similar localization patterns. The NM protein CBU1532 and the Dugway homolog CBUD0454 showed slightly different mitochondrial straining
patterns, with CBU1532 production leading to cell rounding and mitochondria aggregation. Scale bars represent 10 mm.
doi:10.1371/journal.ppat.1002056.g003
Genetic Analysis of the C. burnetii Dot/Icm System
PLoS Pathogens | www.plospathogens.org 5 May 2011 | Volume 7 | Issue 5 | e1002056expressing the 36FLAG-tagged effector proteins. The amount of
SEAP secreted by cells into the culture medium was compared to
the amount of SEAP that remained intracellular after an 8 h
incubation period (Table 1 and Figure 4A). The negative control
was HEK 293 cells transfected with pFLAG alone, showing an
external/internal SEAP activity ratio of 1.2360.46. The positive
control was HEK 293 cells transfected with a plasmid with the
GDP-locked allele ARF1T31N, showing a SEAP activity ratio
of 0.6060.21. Expression of the C. burnetii Dot/Icm effector
CBU0635 was found to interfere with the secretory pathway based
on an external/internal SEAP activity ratio of 0.4960.17.
Consistent with CBU0635 being the only effector that showed a
pattern of localization near the Golgi apparatus when ectopically
expressed in eukaryotic cells (Figure 3B), it was the only effector
found to interfere with the host secretory pathway. Time course
measurements determined that CBU0635-expressing cells had a
defect in the kinetics of SEAP secretion that was similar to cells
producing ARF1T31N (Figure 4B). Thus, CBU0635 has an effector
activity that when overproduced disrupts the mammalian
secretory pathway.
Several C. burnetii Dot/Icm effectors slow yeast
replication when overproduced
Several studies have demonstrated that expression of L.
pneumophila effector proteins in Saccharomyces cerevisiae can interfere
with the rate of yeast replication [37–39]. The L. pneumophila
effector RalF interferes with yeast replication by virtue of it being
able to function as a guanine nucleotide exchange factor for ARF
[37]. Inhibition of yeast replication was the basis for identification
of the L. pneumophila Dot/Icm effectors YlfA and YlfB [37]. To test
whether the C. burnetii Dot/Icm effectors had similar activities,
these proteins were produced in S. cerevisiae and growth was
monitored in liquid YNB supplemented with 2% galactose to
induce effector expression. None of the NM Dot/Icm effectors
conferred a yeast growth phenotype equivalent to that seen with
expression of YlfA (Figure 5A). To determine yeast growth rates,
growth curves were performed in duplicate wells in at least three
independent experiments. The doubling time of each yeast strain
was calculated during the exponential phase of growth between
14 h and 18 h (Figure 5B and Table 1). The negative control
strain consisting of S. cerevisiae pYES2 had a doubling time of
4.460.18 h. Expression of YlfA increased the doubling time to
30.94618.74 h, P=0.013. Six C. burnetii effectors significantly
altered the growth rate of S. cerevisiae; CBU0077 5.3960.29 h
(P=1.9610
24), CBU1524 5.9060.39 h (P=5.0610
25),
CBU1525 5.1060.16 h (P=5.2610
24), CBU1776 4.9960.27 h
(P=0.0054), CBU1823 5.4660.29 h (P=1.7610
24) and
CBU2052 5.4060.32 h (P=5.5610
24). Thus, expression of these
six C. burnetii proteins moderately slows yeast replication.
The Dot/Icm secretion system is essential for C. burnetii
intracellular replication
To determine the cumulative role effector proteins may play
during infection of host cells by C. burnetii, a genetic screen was
initiated to identify C. burnetii having a gene essential for Dot/Icm
transporter function disrupted. Towards this end a mariner-based
Himar1 C9 transposase system was used to generate random
insertions in the chromosome of C. burnetii NM [40]. Kanamycin-
resistant transposon mutants of C. burnetii were selected on defined
ACCM medium and then screened by PCR for insertions into the
dot/icm locus. A mutant was isolated with the transposon inserted
at base 1569472 in the chromosome, disrupting the icmL gene (also
called icmL.1 and dotI) predicted to be essential for function of the
Dot/Icm system (Figure 6A). Southern blot analysis and PCR
amplification of the insertion site was used to confirm the site of
transposon integration and to determine that there was a single
copy of the transposon in this mutant (Figure 6B and C).
To determine whether inactivation of the Dot/Icm system would
influence the ability of C. burnetii to replicate within eukaryotic host
cells, both HeLa and Vero cells were infected at a multiplicity of
infection (MOI) of 50 with either the parental strain C. burnetii NM
phase II or the isogenic icmL::Tn mutant and bacterial replication
was assayed over a period of seven days (Figure 6D and E). No
replication of the icmL::Tn mutant was observed in either cell line.
The isogenic C. burnetii NM phase II strain with a functional Dot/
Icm system demonstrated a 100-fold increase ingenome equivalents
over the same period. Immunofluorescence microscopy of infected
HeLa cells stained with an anti-Coxiella antibody revealed the
formation of large CCVs containing replicating C. burnetii NM, and
a complete absence of large vacuoles containing replicating bacteria
for the isogenic icmL::Tn mutant (Figure 6H). The intracellular
replication defect observed for the isogenic icmL::Tn mutant was
similar to that observed for C. burnetii NM phase II cultured with
host cells in medium containing chloramphenicol (Figure 6D, E and
H). Importantly, the icmL::Tn mutant grew at an equivalent rate to
the control strain of C. burnetii in the defined medium ACCM
(Figure S6), and the intracellular replication defect was not a
consequence of reduced entry, as the icmL::Tn mutant had an
equivalent capacity to enter HeLa cells as the isogenic control strain
(Figure S6). Furthermore, viable icmL::Tn mutant bacteria were
recovered from HeLa cells at 24 h, 72 h and 120 h post-infection
(Figure S6), suggesting that the Dot/Icm apparatus is not essential
for survival within HeLa cells.
Table 1. Characteristics of C. burnetii effector proteins.
NM
effector Localization
A
SEAP
Assay
B
Yeast Doubling
Time
C
CBU0077 Lysosomal membrane 1.3360.38 5.39±0.29
CBU0080 Cytoplasmic 0.9460.32 4.2160.29
CBU0295 Cytoplasmic 0.8760.11 4.7760.32
CBU0329 Cytoplasmic 0.9560.22 4.8560.35
CBU0425 Cytoplasmic 0.8760.13 4.4060.22
CBU0635 Golgi, vesicles 0.49±0.17 3.6860.19
CBU1107 Cytoplasmic 1.0760.21 4.3860.16
CBU1108 Cytoplasmic 1.3760.33 4.8860.30
CBU1524 Nucleus 1.0960.30 5.90±0.39
CBU1525 Cytoplasmic 1.1860.36 5.10±0.16
CBU1532 Mitochondria 0.9160.09 4.6660.24
CBU1776 Cytoplasmic 0.9960.08 4.99±0.27
CBU1823 Cytoplasmic 0.9060.25 5.45±0.26
CBU1825 Mitochondria 0.8560.21 4.0460.38
CBU1963 Cytoplasmic 0.9560.20 4.9460.44
CBU2052 Cytoplasmic 0.9160.13 5.40±0.32
CBU2056 Cytoplasmic 0.8960.01 4.8360.27
CBU2059 Cytoplasmic 0.8860.37 4.3560.42
ALocalization of ectopically expressed FLAG-tagged protein in HeLa cells
(Figure 3 and Figure S4).
BExternal/Internal SEAP activity (Figure 4).
CDoubling time in hours during logarithmic phase (Figure 5).
Values in bold represent results significantly different to control experiments
(P,0.01).
doi:10.1371/journal.ppat.1002056.t001
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of the icmL::Tn mutant resulted from a loss of Dot/Icm system
function. The icmL gene is centrally located in a putative operon
that begins with the icmQ gene and terminates after the icmC gene
(Figure 6A), which would predict that polar effects resulting from
the insertion of the transposon in the icmL gene would also limit
the production of the downstream icmKEGC gene products. For
this reason, complementation studies were conducted using two
different plasmids. The plasmid pIcmL contained only the icmL
gene, whereas, the plasmid pQC contained the entire operon from
icmQ to icmC. The ability of these plasmids to complement the
icmL::Tn mutation was determined by assaying intracellular
replication of the resulting C. burnetii strains containing these
plasmids in HeLa and Vero cells compared to a positive control
strain, which was C. burnetii NM containing a plasmid encoding the
ß-lactamase gene (pBlaM). Intracellular replication of the icmL::Tn
mutant was fully restored by the plasmid pQC as indicated by the
increase in genome equivalents over time (Figure 6F, G) and the
appearance of vacuoles containing replicating bacteria at day 5
post-infection (Figure 6H). Thus, the intracellular growth defect
observed for the icmL::Tn mutant is linked genetically to the region
of the transposon insertion and is caused by inactivation of the
Dot/Icm system. As predicted, the plasmid pIcmL did not
complement the icmL::Tn mutation, consistent with the tranposon
insertion having a polar effect on production of the downstream
icm gene products. These studies demonstrate that the Dot/Icm
system and the cumulative activities of the translocated effectors
are essential for establishment of a vacuole that supports C. burnetii
replication in mammalian host cells.
Demonstration of Dot/Icm-dependent protein
translocation in C. burnetii
To validate that the effectors identified in this screen are
delivered into host cells during infection by C. burnetii, a polyclonal
antibody specific for the conserved C. burnetii Dot/Icm effector
CBU0077 was generated (Figure 7A). HeLa cells persistently
Figure 4. CBU0635 interferes with host protein secretion. The impact of C. burnetii Dot/Icm effectors on the host cell secretory pathway was
examined by monitoring secretion of the SEAP protein into the culture supernatant. (A) HEK 293 cells were co-transfected with pSEAP and the
plasmid encoding the indicated effector protein or the GDP-locked ARF1T31N protein (pArf1-T31N) or empty vector (pFLAG). External and internal
SEAP activity was measured. The grey bars show that there was a significant decrease in the external/internal ratio of SEAP activity observed upon
ectopic expression of ARF1T31N (P=0.0012) or CBU0635 (P=0.0057) in comparison to HEK 293 cells transfected with pFLAG alone (black bar).
Expression of all other C. burnetii effectors did not significantly the ratio of SEAP activity (white bars). (B). SEAP activity (y-axis) was measured at the
indicated times after cells were washed and new culture medium was added (x-axis) Data show SEAP ratios for cells with vector alone (pFLAG; black
triangles), cells producing CBU0635 (pCBU0635; open squares) and cells producing ARF1T31N (grey circles). A similar defect in SEAP secretion was
observed in cells producing ARF1T31N as in cells producing CBU0635.
doi:10.1371/journal.ppat.1002056.g004
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that contained host proteins and bacterial proteins secreted or
translocated during infection, and a pellet fraction containing
C. burnetii proteins that remain associated with intact bacterial
cells and insoluble host debris. Immunoblot analysis revealed
CBU0077 in the fraction of secreted/translocated bacterial
proteins, whereas, the C. burnetii translation elongation factor
EF-Ts, which is not a secreted/translocated protein, was detected
only in the pellet fraction. These data indicate CBU0077 is
produced and translocated out of the bacterial cell during
infection. When de novo synthesis of bacterial proteins in the
infected cells was prevented by treatment with chloramphenicol
for 16 h prior to fractionation, a slight decrease in the amount of
CBU0077 was found for the secreted fraction and the pellet
Figure 5. Several C. burnetii effectors slow yeast replication. (A) Yeast strains were grown in YNB supplemented with 2% galactose to induce
the expression of the indicated effector proteins listed in the legend on the right. The plots show yeast replication as determined by measuring the
optical density of the culture at 600 nm (OD 600 nm, y-axis) every 30 min (x-axis) for a period of 36 h. Growth of S. cerevisiae expressing C. burnetii
effectors were compared to controls that included S. cerevisiae containing the vector control (pYES2; open squares) and S. cerevisiae producing the L.
pneumophila effector YlfA (pJG4-5:YlfA; red triangles). Effectors that resulted in a delay in the doubling rate of S. cerevisiae are highlighted with red
symbols. (B) The doubling time of S. cerevisiae producing the indicated effector proteins was calculated during the exponential phase of growth from
the growth curves shown in panel A. Effectors that resulted in a significant increase in doubling time compared to S. cerevisiae pYES2 are highlighted
in open boxes (P,0.01). Data represent the mean doubling time 6 SD determined from at least 3 independent growth curves.
doi:10.1371/journal.ppat.1002056.g005
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PLoS Pathogens | www.plospathogens.org 8 May 2011 | Volume 7 | Issue 5 | e1002056Figure 6. The C. burnetii Dot/Icm system is essential for intracellular replication. (A) A clone of C. burnetii with a 3.69 kb transposon inserted
in the icmL gene (dotI/icmL.1) was isolated after enrichment on medium containing kanamycin. The schematic shows the predicted location and
orientation of the transposon in icmL as determined by sequence analysis. The location of probes and restriction sites used to validate the site of
transposon insertion by PCR and Southern hybridization are indicated. (B) As indicated, genomic DNA digested with HindIII isolated from the
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both bacterial and host cell compartments (Figure 7A).
To independently address whether CBU0077 is translocated
during infection, a ß-lactamase-based translocation assay was used.
In this assay, a derivative of ß-lactamase (BlaM) that lacks a signal
sequence is fused to the amino terminus of a potential Dot/Icm
effector. The delivery of a BlaM hybrid into the host cytosol is
monitored using the substrate CCF4-AM. When BlaM fusion
proteins are delivered into the host cell cytosol the CCF4-AM
molecule is cleaved, resulting in a shift in fluorescence emission
from 535 nm (Green) to 460 nm (Blue) when excited at 415 nm.
Plasmids encoding blaM alone and the blaM-CBU0077 fusion were
introduced into C. burnetii NM phase II and the isogenic icmL::Tn
mutant. Production of the expected BlaM proteins was confirmed
by immunoblot analysis (Figure S7). These C. burnetii strains
producing BlaM proteins were used to infect HeLa cells, and
cleavage of the CCF4-AM substrate was measured at 4 h, 8 h,
12 h, 16 h and 24 h post infection (Figure 7B). Translocation of
BlaM and BlaM-CBU0077 was undetectable at 4 h post infection
in all strains examined. At 8 h post infection, translocation of
BlaM-CBU0077 was detected by C. burnetii NM phase II, with a
460 nm/535 nm fluorescence emission ratio relative to uninfected
cells of 1.5860.28 compared to 1.0660.22 for the strain
expressing BlaM alone. This signal continued to increase at 12 h
(3.0360.43), at 16 h (3.9060.95) and at 24 h (9.1764.96).
Translocation of the BlaM protein alone by C. burnetii was not
detected for any strain at any time point, confirming that delivery
of BlaM into the host cytosol required fusion to the type IV
effector CBU0077. Most importantly, translocation of BlaM-
CBU0077 was not detected using the icmL::Tn mutant, demon-
strating that the Dot/Icm apparatus is essential for delivery of this
effector into the host cytosol.
Single cell assays were conducted to compare the efficiency of C.
burnetii entry with the efficiency of effector translocation. Host cells
were infected at different multiplicities with isogenic C. burnetii NM
strains producing BlaM-CBU0077, and fluorescence microscopy
was used to measure the efficiencies of infection and effector
protein translocation. As the multiplicity of infection increased
there was a dose-dependent increase in the number of cells that
were infected by C. burnetii (Figure 7C). There was no difference
observed in the infection efficiencies of the control C. burnetii NM
strain compared to the isogenic icmL::Tn mutant. A dose-
dependent increase in the number of cells receiving the BlaM-
CBU0077 protein that closely mirrored the uptake efficiency was
observed after infection with the control C. burnetii NM strain
(Figure 7D), as determined by counting cells with a positive
emission signal at 460 nm resulting from cleavage of the CCF4-
AM substrate by the translocated fusion protein. No translocation
of BlaM-CBU0077 was observed after infection of cells with the
icmL::Tn mutant, even though uptake was similar to that observed
for the isogenic C. burnetii NM control. These data indicate that
most of the cells that are infected by C. burnetii NM are subject to
Dot/Icm-dependent translocation of CBU0077.
The delivery of BlaM fusions to CBU0635 and CBU1524 was
also assessed to validate that other effectors identified in this study
were translocated into host cells during infection by C. burnetii by a
Dot/Icm-dependent mechanism. BlaM-CBU0635 and BlaM-
CBU1524 were produced in roughly equal amounts in C. burnetii
NM and the isogenic icmL::Tn mutant (Figure S7). HeLa cells were
scored for translocation of the BlaM fusion proteins after a 24 h
infection period. Translocation-positive cells were detected after
infection of host cells with C. burnetii NM producing BlaM-
CBU0077, BlaM-CBU0635 and BlaM-CBU1524, however, there
were no translocation-positive cells detected after host cells
infection with the isogenic icmL::Tn mutant producing these
fusion proteins (Figure 7E). Thus, effectors identified using the L.
pneumophila system are engaged and translocated into host cells
during C. burnetii infection by a Dot/Icm-dependent mechanism.
Discussion
In this study a random screen was conducted to identify novel
effectors produced by C. burnetii. Because type IV secretion systems
recognize translocation signals at the carboxyl terminus of
effectors, a strategy was employed in which a Cya reporter that
lacks a translocation signal was used to monitor the presence of
coding determinants fused at the carboxyl terminus of the protein
that enabled Cya to be engaged and delivered into host cells by the
Dot/Icm system. This approach was successful at identifying C.
burnetii proteins delivered into host cells by the Dot/Icm system,
demonstrating the feasibility in using type IV translocation signal
screening as a means to identify effectors.
Four of the effector proteins identified here (CBU1524,
CBU1823, CBU1825 and CBU2052) were reported recently as
Dot/Icm substrates in an independent study that was based on
identifying effectors based on sequence motifs and protein
interaction properties [41], however, the majority of the effectors
identified using the type IV secretion signal screen were not
uncovered using these predictions. This highlights the benefit of
using functional screens for type IV secretion signals as a means to
C. burnetii NM strain and the isogenic icmL::Tn mutant was analyzed by Southern hybridization using a probe derived from the icmL gene and a probe
derived from the transposon. As predicted from the schematic in panel A, the icmL probe identified a single band of 4.2 kb in the NM strain, and two
bands of 3.3 kb and 2.5 kb in the icmL::Tn mutant because of a new HindIII site introduced into the icmL locus by the transposon. When a probe
homologous to the transposon was used (Tn probe), a single band was identified in the icmL::Tn mutant, indicating that this strain has a single
insertion of the transposon in the chromosome. (C) PCR amplification of genomic DNA from NM and the icmL::Tn mutant using primer sets shown in
panel A confirm the predicted location and orientation of the transposon insertion in icmL, and that the transposon is retained by the icmL::Tn strain
after introduction of a plasmid encoding icmL (pIcmL) or a plasmid encoding the entire operon harboring icmL (pQC). (D,E) The ability of the icmL::Tn
mutant to replicate in HeLa (D) and Vero (E) cells was determined by measuring genomic equivalents (y-axis) at the indicated times after infection (x-
axis). There was a 50 to 100-fold increase over 7 days in C. burnetii NM genomic units (black squares). No significant increase in genomic units was
detected for the icmL::Tn mutant (white squares) or C. burnetii NM treated with 10 mg/ml chloramphenicol (gray squares). (F,G) The ability of the
icmL::Tn mutant to replicate in HeLa (F) and Vero (G) cells was determined by measuring genomic equivalents (y-axis) at the indicated times after
infection (x-axis). Replication was observed for C. burnetii NM containing pBlaM (black squares) and the icmL::Tn mutant containing the plasmid pQC
(black triangles). The icmL::Tn mutant containing the vector pBlaM (white squares) or for the icmL::Tn mutant containing pIcmL (white triangles).
Graphs represent the mean 6 SD of at least three independent experiments. (H) Fluorescence micrographs were acquired after infection of HeLa cells
for 5 days by the strains of C. burnetii indicated. An anti-Coxiella antibody (green) was used to visualize intracellular bacteria and the nucleus of the
host cell was visualized by DAPI staining (blue). Replicating bacteria in large vacuoles were observed for cells infected with C. burnetii NM, C. burnetii
NM containing pBlaM and the icmL::Tn mutant containing pQC. Only individual bacteria were observed inside the host cells infected with the icmL::Tn
mutant, C. burnetii NM in medium with chloramphenicol, icmL::Tn containing pBlaM and icmL::Tn containing pIcmL (indicated with arrows). These are
representative images from at least three independent experiments.
doi:10.1371/journal.ppat.1002056.g006
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PLoS Pathogens | www.plospathogens.org 10 May 2011 | Volume 7 | Issue 5 | e1002056Figure 7. The C. burnetii Dot/Icm secretion system is required for effector translocation. (A) HeLa cells either infected with C. burnetii NM
or uninfected were incubated with or without chloramphenicol (CM) and cellular lysates were separated into supernatant and pellet fractions.
Immunoblot analysis was used to detect CBU0077 (top panel; a-77) and EF-Ts (bottom panel; a-EF-Ts). The CBU0077 protein was detected in both the
supernatant fraction containing proteins secreted during infection and in the pellet fraction containing intact bacteria. The cell associated EF-Ts
protein was detected only in the pellet fraction containing intact bacterial cells. The addition of chloramphenicol resulted in a slight drop in levels of
CBU0077 detected in the supernatant, suggesting the secreted protein has a relatively long half-life. Similar results were obtained from three
independent experiments. (B) C. burnetii NM (black bars) and the icmL::Tn mutant (white bars) containing either pBlaM or pBlaM-77 were used to
infect HeLa cells for the times indicated (x-axis). Translocation of the BlaM and BlaM-CBU0077 fusion protein by the respective strains was determined
by measuring the change in the 460 nm/535 nm fluorescence emission ratio resulting from cleavage of the CCF4-AM substrate (y-axis). Results
represent the mean 6 SD obtained from triplicate samples. (C, D) HeLa cells were infected in parallel with C. burnetii NM producing BlaM-CBU0077 or
the icmL::Tn strain producing BlaM-CBU0077 at the multiplicities of infection (MOI) indicated on the x-axis. Fluorescence microscopy was used to
determine the percent of cells infected by the two strains (C) and the number of cells that stained positive for BlaM translocation (D) Results represent
the mean 6 SD obtained from triplicate samples. (E) Fluorescence micrographs of HeLa cells that were infected for 24 h with either C. burnetii NM or
the icmL::Tn strains producing either BlaM alone or BlaM fusions to CBU0077 (pBlaM-77), CBU0635 (pBlaM-0635) or CBU1524 (pBlaM-1524). Emission
at 535 nm (green) identifies the CCF4-AM-loaded cells and emission at 460 nm (blue) indicates cleavage of CCF4-AM in the cytosol of the infected cell
resulting from translocation of the BlaM fusion protein. The percent of cells that were BlaM positive (blue) was determined for each infection
condition and the mean 6 SD from three independent experiments is displayed in the bottom right corner of each representative micrograph.
doi:10.1371/journal.ppat.1002056.g007
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plasmid QpH1 in C. burnetii encodes several Dot/Icm effectors
[42]. Interestingly, none of the effectors identified here using the
type IV secretion signal screen were plasmid encoded. This may
reflect a low abundance of QpH1 in the genomic DNA
preparation used to make the Cya fusion protein library. Other
reasons for effectors not being identified in this screen for type IV
secretion signals include a lack of suitable SauIIIA sites that would
be needed for in an in-frame fusion to Cya, and the potential to
miss effectors translocated at low levels because the screening
approach relied on a strong signal being generated by a single
clone in a mixed pool. These limitations should be considered in
any future screens for type IV secretion signals, and with slight
modifications to the DNA fragmentation method and screening
protocol, minor improvements should enable more complete
coverage of the genome.
An analysis was performed in which the effectors found in the
NM strain were compared to genes from other sequenced strains
of C. burnetii. As was observed for members of the Ank family of
effector proteins [25], a significant degree of heterogeneity was
revealed among the Dot/Icm effectors identified in this study.
Interestingly, what appears to be effector pseudogenization is
prevalent in strains of C. burnetii capable of causing acute and
chronic Q fever in humans. The evolutionary and pathogenic
significance toward Dot/Icm effector pseudogenization remains
unclear. Dugway possesses the largest genome and fewest
pseudogenes of the sequenced C. burnetii isolates [31]. This implies
that a large repertoire of functional effectors could be beneficial, as
it may enable C. burnetii to persist and be transmitted by many
different animals in nature without causing disease to their hosts.
The loss of effectors appears to correlate with a change in the
relationship between C. burnetii and mammalian hosts from
commensalism to parasitism, which would indicate that a balanced
repertoire of effectors is important in preventing responses that
would result in host pathology.
Further investigation is required to determine whether the
truncated NM Dot/Icm effectors identified here are non-
functional or whether these genes still produce functional effectors
that mediate the same or distinct activities compared to the larger
proteins predicted to be produced by alleles found in other strains
of C. burnetii. Because effectors are modular proteins that can have
multiple enzymatic domains with different effector functions, it
remains possible that some of the mutations resulting in truncation
of a NM protein occur through positive selection, where the
truncated effector has evolved in such a way that it retains a
beneficial enzymatic activity and discards an activity that is no
longer being selected for in the infected host. CBU0080 and the
homologue CbuK1976 may provide such an example. Ectopically
expressed CbuK1976 has an affinity for the host nucleus, whereas,
the truncated NM protein CBU0080, which lacks a helix loop
helix motif found in CbuK1976, is retained in the cytoplasm.
Conceivably, CBU0080 could be a functional effector where
elimination of the helix loop helix motif is the result of positive
selection as it may enhance an activity associated with the C-
terminal region of the protein. The effectors CBU1107 and
CBU1108 provide another intriguing comparison. CBU1107 and
CBU1108 have independent determinants that confer Dot/Icm-
dependent translocation. In Dugway, genes encoding these two
effectors are fused to generate the large protein CBUD1210,
which would represent a hybrid effector. It is possible that a
mutation in NM resulting in two gene products, CBU1107 and
CBU1108, was positively selected because it allows more precise
regulation of two effector functions compared to the hybrid
protein CBUD1210. Alternatively, CBUD1210 could represent
fusion of the two genes encoding CBU1107 and CBU1108 and
this fusion was positively selected because it links two effectors that
may act in concert. Although these examples remain highly
speculative, it illustrates how studies on C. burnetii effector evolution
could provide novel insight into how the repertoire of Dot/Icm
effectors is being shaped by host interactions.
Several approaches were used to investigate whether the
identified effector proteins had activities that would perturb
eukaryotic cell functions (summarized in Table 1). C. burnetii Dot/
Icm effector proteins are likely to modulate a broad array of
eukaryotic cellular processes. This is supported by the diversity
observed in the localization of these effectors produced in
mammalian host cells. Although several effectors were found
diffusely in the cytosol of the mammalian cell, there were clear
examples of specific localization of effectors to the nucleus,
mitochondria, lysosomes and a perinuclear region near the Golgi
apparatus. Consistent with its localization near the Golgi
apparatus, the effector CBU0635 disrupted membrane transport
in the host secretory pathway as determined by a defect in SEAP
secretion. The localization of CBU0077 with lysosomes was also
intriguing, as the CCV is an organelle derived from lysosomes.
The observation that CBU0077 is highly conserved in all
sequenced strains of C. burnetii makes this protein an attractive
candidate for being directly involved in processes important for
CCV biogenesis. Isolation of a C. burnetii mutant deficient in
CBU0077 may provide some clues as to the role this effector plays
in modulating host processes during infection.
Six of the C. burnetii effectors were found to moderately affect the
replication of yeast when overproduced. These differences were
minor compared to what is observed when many of the L.
pneumophila effectors are produced in S. cerevisiae, where replication
and viability are affected so severely that the yeast are unable to
form single colonies on agar plates. Because of the severity of these
defects, several L. pneumophila Dot/Icm effector proteins were
identified based on their capacity to interfere with yeast viability
[37]. Furthermore, examination of the impact of a large cohort of
L. pneumophila Dot/Icm effectors showed that in excess of 60% of
these proteins significantly decrease yeast growth and/or viability
[38]. The observation that none of the C. burnetii effectors had this
dramatic effect on yeast viability could relate to the different roles
the Dot/Icm system is likely to play during infection by these two
pathogens. For L. pneumophila, the Dot/Icm system has evolved to
modulate cellular functions in evolutionarily diverse protozoan
hosts and to create a vacuole that is derived from the endoplasmic
reticulum. Many of the targets that have been identified for L.
pneumophila effectors are proteins that are highly conserved
throughout the eukaryotic kingdom. By contrast, C. burnetii infects
mammals and has reprogrammed its effector repertoire to survive
and replicate inside mammalian host cells. As such, there are likely
to be effectors that have evolved to manipulate targets specific to
mammalian cells and may not recognize targets in more primitive
eukaryotic cells, such as yeast. An example of this is the effector
AnkG that blocks apoptosis by targeting the host protein p32,
which is found in mammals but not in yeast or protozoa [26].
Studies on the effector CBU0077 showed that this protein was
produced during infection. Both the endogenous CBU0077
protein and the BlaM-CBU0077 fusion protein were delivered
into host cells. Because the BlaM detection system is based on
delivery of a robust enzyme into the host cytosol, the assay is
sensitive and can detect translocation of small amounts of a fusion
protein. Detectible levels of effector translocation were first
detected at 8 h post infection. The inability to detect translocation
of BlaM-CBU0077 at 4 h suggests that the C. burnetii Dot/Icm
system is not fully functional during the early stages of host cell
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translocation of effectors by the L. pneumophila Dot/Icm system
[43], which implies that bacterial metabolism is important for the
functioning of this apparatus. It has been shown that infectious
forms of C. burnetii that are environmentally resistant do not
become metabolically active until they gain access to a low pH
environment [3,44,45]. Thus, it is possible that the Dot/Icm
system is not functioning in the early events in vacuole biogenesis
and only becomes active once the C. burnetii have been transported
through the endocytic pathway of the host cell to an acidified
lysosomal compartment. There are several logical reasons why the
Dot/Icm system may not be needed by C. burnetii during these
early stages of infection. Because fusion of phagosomes with
lysosomes represents a default membrane transport pathway that
most bacteria follow after uptake, the Dot/Icm system should not
be needed to promote delivery of the bacteria to this preferred
location. Additionally, it is now well established that mammalian
cells have several innate immune sensors that can detect the
activities of the L. pneumophila Dot/Icm system during the early
stages of infection [46,47]. Thus, not having the Dot/icm system
functioning during these early infection events may help delay or
prevent innate immune detection of C. burnetii.
Recent advances in axenic cultivation of C. burnetii [48] and
newly developed genetic tools developed to study this organism
[40] were used to isolate a transposon insertion mutant that lacked
a functional Dot/Icm apparatus. As expected, the BlaM-
CBU0077, BlaM-CBU0635 and BlaM-CBU1524 proteins were
not delivered into host cells by the icmL::Tn mutant, providing
additional evidence that translocation of these effectors by C.
burnetii requires a functional Dot/Icm system. Similar to what was
shown initially for L. pneumophila dot and icm mutants [12,13], the
ability of the C. burnetii icmL::Tn mutant to grow on synthetic
medium as efficiently as the isogenic parental strain demonstrates
conclusively that the Dot/Icm system is not essential for
replication extracellularly. Most importantly, when the icmL::Tn
was used to infect mammalian cells, there was a severe defect in
the ability of this mutant to replicate intracellularly that was linked
genetically to the inactivation of the Dot/Icm system by insertion
of the transposon.
These data demonstrate that the Dot/Icm system plays an
essential role in the process of intracellular infection of mammalian
host cells, which means that the collective activities of the effector
proteins delivered into cells by the Dot/Icm system are needed for
the successful establishment and maintenance of the specialized
vacuole in which this pathogen resides. Thus, determining the
biochemical activities of the novel C. burnetii effectors identified in
this study should help elucidate the mechanisms by which this
intracellular pathogen can persist and grow inside mammalian
host cells.
Methods
Reagents
Unless otherwise noted, chemicals were purchased from Sigma
(St. Louis, MO). Restriction enzymes and molecular cloning
enzymes were purchased from New England Biolabs (NEB;
Ipswich, MA). Cell culture media and fetal bovine serum (FBS)
was obtained from Invitrogen (Carlsbad, CA). Protease inhibitor
cocktail and Fugene 6 transfection reagent were from Roche
Applied Sciences (Indianapolis, IN).
Host cell lines and bacterial strains
CHO cells expressing FccRII [28], HeLa 229, Vero and HEK
293 cells were maintained in Dulbecco’s Modified Eagle’s Media
(DMEM) supplemented with 10% heat-inactivated FBS at 37uCi n
5%CO2 unless otherwise described.
A plaque-purified isolate of Coxiella burnetii phase II Nine Mile
strain, a generous gift from Dr. T. Hackstadt of the Rocky
Mountain Laboratories (Hamilton, MT) was propagated in
eukaryotic cell lines in DMEM supplemented with 5% FBS at
37uCi n5 %C O 2 or ACCM at 37uCi n5 %C O 2 and 2.5% O2 as
described previously [48]. When required chloramphenicol and
kanamycin were used in C. burnetii ACCM cultures at 3 mg/ml and
275 mg/ml respectively.
Legionella pneumophila strains, CR39 and CR58 ( DdotA), which
are isogenic derivatives of the serogroup 1 strain LP01 [13,49],
were grown on either charcoal-yeast extract (CYE) plates or in
ACES-buffered yeast extract (AYE) broth containing chloram-
phenicol (6.25 mg/ml) as previously described [50]. E. coli strains
were cultivated on Luria-Bertani (LB) plates or broth supplement-
ed with chloramphenicol (25 mg/ml), ampicillin (100 mg/ml) or
kanamycin (50 mg/ml) as appropriate.
Construction of C. burnetii genomic DNA library
Purified C. burnetii were pelleted for 5 min at 80006gi na
microcentrifuge. Pellets were resuspended in 50 mM Tris-HCl,
pH 8.0 containing 50 mM EDTA, pH 8.0. Lysozyme was added
to a final concentration of 5 mg/ml and incubated at RT with
gentle rocking. After 30 min, sodium dodecyl sulfate (SDS) and
proteinase K (Roche Applied Sciences) were added to final
concentrations of 1% and 10 mg/ml, respectively, and incubated
for 1 h at RT with gentle rocking. Genomic DNA was extracted
with phenol, phenol-chloroform, and chloroform; precipitated
with ethanol; air dried; then resuspended in 10 mM Tris-HCl,
pH 8.0 containing 1 mM EDTA, pH 8.0. Genomic DNA was
partially digested with Sau3AI for 1 h at 37uC, separated by gel
electrophoresis, and purified from a Low Melt agarose gel
(American Bioanalytical, Natick, MA) as follows. DNA fragments
between 2 kb and 4 kb were excised from the gel, placed in
eppendorf tubes, and heated to 70uC for 10 min. An equal volume
of prewarmed phenol (40uC) was added to the melted agarose,
mixed, and separated by 5 min centrifugation at 16,0006g. The
upper aqueous layer was chloroform extracted, ethanol precipi-
tated and resuspended in 10 mM Tris-HCl, pH 8.0 containing
1 mM EDTA, pH 8.0.
Plasmid, pEC33, was generated from pM45-ralF [27] as follows:
plasmid was digested with BamHI and PstI, gel purified to remove
ralF gene insert, treated with DNA polymerase I (Klenow)
fragment, and ligated to preserve the BamHI site (E. Cambronne,
unpublished).
C. burnetii genomic DNA fragments were ligated into BamHI
digested pEC33 resulting in a library of C. burnetii genes fused to
the carboxyl region of the enzymatic domain of the Bordetella
pertussis adenylate cyclase toxin. The genomic library was
transformed into ElectroMax DH10B electroporation competent
E. coli (Invitrogen). The insert efficiency was estimated to be 92%
by restriction enzyme digest of randomly selected clones.
Following amplification in E. coli, the library DNA was purified
by cesium chloride density fractionation and subsequently used to
transform L. pneumophila.
Screening of genomic DNA library
To screen the C. burnetii genomic DNA library for translocation
into mammalian host cells using the Cya fusion strategy [51], L.
pneumophila strain CR39 was transformed with the library of C.
burnetii genes fused to cya by electroporation and the library of
transformants was expanded on CYE plates. The library was
distributed into pools containing approximately 50 transformants
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24 well plates of CYE supplemented with chloramphenicol for 4
days at 37uC. Bacteria from each well were resuspended in AYE
medium, an equal volume of freeze media (4% (w/v) peptone
containing 10% (v/v) glycerol) was added, and the pools were
stored in a 96-well plate format at 280uC.
Briefly, the translocation assay was performed as follows (see
Figure S2). Pools of L. pneumophila expressing Cya-C. burnetii fusion
proteins growing on CYE in 24 well plates were resuspended in
AYE to a concentration of 1610
9 cfu/ml. CHO- FccRII cells were
pretreated for 1 h with an anti-Legionella antibody then infected with
3610
6 L. pneumophila from each pool. After 1 h of incubation at
37uC, monolayers were washed three times with ice-cold PBS and
lysed in coldbuffer containing50 mM HCl and 0.1% (v/v) TX-100
for 30 min at 4uC. The lysates were boiled for 5 min and
neutralized with 30 mM NaOH. Total cAMP was extracted and
quantified using cAMP Biotrak Enzymeimmunoassay System (GE
Healthcare, Piscataway, NJ). Pools that registered cAMP levels of
2.5 times over vector control were considered positive.
Individual colonies from pools that were scored positive in the
cAMP assay were isolated and arrayed in 96 well plates containing
CYE agar. Secondary screening was conducted by pooling the 12
clones in each row to identify which row contained a positive clone
(Figure S2B). Rows that gave a positive cAMP signal were further
analyzed by testing individual clones present in the positive rows
for translocation (Figure S2C).
Plasmid DNA from individual L. pneumophila transformants that
were identified using the above screening procedure was isolated
as follows. Bacteria from a confluent region on a CYE plate were
used to inoculate AYE containing chloramphenicol and grown
overnight at 37uC. Bacteria were pelleted and resuspended in
STET buffer (8% (w/v) sucrose, 50 mM Tris-HCl, pH 8.0,
50 mM EDTA, pH 8.0, 0.1% (v/v) Triton X-100). Fresh
lysozyme (2 mg/ml) was added and incubated for 5 min at RT
before boiling the samples for 1 min. Plasmid DNA was isolated
from aqueous phase using Miniprep Express Matrix (Bio101, La
Jolla, CA) as per manufacturer’s instructions. To sequence fusion
junctions, plasmid DNA was isolated from E. coli transformants as
described above and sequenced by W.M Keck Foundation
Biotechnology Resource Laboratory (Yale University).
Plasmid construction
Full-length genes of constructs containing in-frame fusions of
putative effectors were amplified by PCR with sequence specific
primers containing BamHI and PstI sites for cloning into pEC33
(Table S3). pcDNA4/TO (Invitrogen) with a N-terminal 36FLAG
tag (pFLAG) was used to clone Dot/Icm effectors from NM,
Dugway, G and K isolates through BamHI and XhoIo rBamHI and
EcoRI for CBU0295 and CBU1823 or BamHI and XbaI for
CBU2059 (Table S3). Plasmids encoding in frame fusions between
the coding regions of BlaM and the effector proteins were
generated by inserting the gene encoding the effector at a SalI site
located at the 39 end of the blaM gene in the plasmid pJB-CAT-
BlaM [42] using the In-Fusion Advantage PCR Cloning system as
described by the manufacturer (Clontech Laboratories, Palo Alto,
CA). For complementation studies the icmL gene and the
icmQPONL2L1KEGC operon were ligated into the plasmid pJB-
CAT-BlaM after digestion of the DNA with PstI and SalIt o
remove the blaM gene, generating the plasmids pIcmL and pQC,
respectively.
RT-PCR analysis
Total RNA was extracted from C. burnetii purified from
persistently infected CHO- FccRII cells using a Trizol Max
Bacterial Isolation kit (Invitrogen) as per manufacturer’s instruc-
tions. RNA was treated with RNase-free DNase (Qiagen,
Valencia, CA) and purified using RNeasy mini spin columns
(Qiagen) as per manufacturer’s instructions for RNA cleanup. First
strand cDNA was synthesized from 5 mg total RNA using gene
specific RT primers (Table S3) with the Superscript III First
Strand Synthesis System for RT-PCR (Invitrogen). PCR reactions
were performed from cDNA prepared with or without Superscript
III reverse transcriptase using gene specific primers and Elongase
enzyme mix (Invitrogen).
Fluorescence microscopy
To examine the localization of ectopically produced FLAG-
tagged proteins, HeLa 229 or CHO- FccRII cells were plated on
12 mm glass coverslips in 24-well plates at a density of 3610
4
cells/well. Cells were transfected with plasmid DNA using Fugene
6 (Roche) or Lipofectamine 2000 (Invitrogen). Eighteen hours
post-transfection cells were fixed using 4% paraformaldehyde and
permeablized with Triton X-100. Samples were incubated with
primary antibodies in 2% BSA at the following concentrations;
anti-FLAG (Sigma) 1:300, anti-LAMP1 H4A3 (Developmental
Studies Hybridoma Bank) 1:50, anti-TOM22 (Sigma) 1:250, anti-
GM130 (BD) 1:250, anti-C. burnetii 1:10000. Secondary antibodies,
Alexa Fluor 488 and 546 (Invitrogen) were used at 1:2000 in 2%
BSA. Bacterial and host cell DNA was labeled using 0.1 mg/ml
4,6-diamidino-2-phenylindole (DAPI). Coverslips were mounted
on slides using ProLong Gold (Invitrogen). Images were acquired
with a Zeiss LSM510 microscope using a 1006/1.4 numerical
aperture objective. Images were exported as TIFF files and labeled
with Adobe Illustrator. Similar results were obtained in at least
three independent experiments.
CBU0077 translocation assay
Uninfected or C. burnetii-infected HeLa cells were incubated
with chloramphenicol (25 mg/ml) or DMSO for 16 h at 37uCi n
5%CO2. Cells were washed with Hanks buffered salt solution
(HBSS, Invitrogen) containing 16protease inhibitor cocktail (PI)
then lysed with ice-cold HBSS containing PI and 0.1% Triton X-
100. The cells were centrifuged for 10 min at 16,000g at 4uCt o
separate the soluble fraction containing secreted and translocated
bacterial proteins from the insoluble fraction, which contained
intact bacteria. The soluble fraction was clarified using a 0.22 mm
pore-size filter (Millipore, Bedford, MA) and proteins were
concentrated by trichloroacetic acid precipitation. Samples from
both the soluble and insoluble fractions were separated by SDS-
PAGE, transferred to PVDF (Millipore) and probed with anti-
CBU0077 or anti-EF-Ts [52] as a bacterial lysis control. Similar
results were obtained from three independent experiments.
Yeast growth assay
Genes encoding Dot/Icm effectors were amplified from NM
gDNA by PCR with sequence specific primers containing a BamHI
site, Kozak sequence and ATG, if applicable, at the 59 end, and an
XbaIo rSphI at the 39end (Table S3). The PCR products were
cloned into pYES2 (Invitrogen), and introduced in competent
S.cerevisiae. Overnight liquid YNB-glucose cultures were pelleted
and washed once with YNB before being resuspended to an OD
600 nm of approximately 0.03 in YNB-galactose. 200 ml of this
suspension was distributed into duplicate wells of a 96 well tray
and incubated in a Tecan M1000 plate reader at 30uC. OD
600 nm readings were taken every 30 minutes, following a
30 second agitation, for the duration of the time course. Growth
curves were created from at least three independent experiments.
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HEK 293 cells in 24 well plates were co-transfected with 0.2 mg
pSEAP and 0.3 mg of a pFLAG derivative encoding the indicated
Dot/Icm effector or control protein. Approximately 16 h post-
transfection the cells were washed with fresh medium, and a
sample was collected to calculate the background SEAP activity in
the culture supernatant. Following an 8 h incubation period, the
culture medium was collected to assay SEAP levels secreted by the
cells, and an equivalent volume of buffer containing 0.2% Triton
X-100 was applied to the cells to measure the intracellular alkaline
phosphatase activity. Alkaline phosphatase activity was measured
in 96-well format using the Phospha-Light System (Applied
Biosystems). Ratios of extracellular to intracellular SEAP activity
were calculated from at least three independent experiments.
Genetic manipulation of C. burnetii
Plasmid DNA, for introduction into C. burnetii, was purified
using the GeneElute HP Endotoxin Free Plasmid Maxiprep Kit
(Sigma) and concentrated with an Amicon Ultra Centrifugal Filter
(Millipore). This DNA was introduced into axenically grown C.
burnetii by electroporation. Approximately 5610
9 bacteria were
washed twice and resuspended in ice-cold 10% glycerol. Plasmid
DNA was added (10 mg) and the bacteria were electroporated at
18 kV, 500V,2 5mF. Electroporated C. burnetii were resuspended
in 1 ml RPMI and 200 ml of this was used to seed a 20 ml ACCM
culture. After a 24 h recovery, the appropriate antibiotics were
added. Cultures were passaged after 7 days. Following 14 days of
selection in liquid ACCM the bacteria were grown on ACCM
agarose plates to isolate individual transformants.
Southern hybridization
PCR probes for icmL and the transposon were amplified, with
the incorporation of digoxigenin-dUTP, using the primer pairs
icmL.1F/icmL.1R and TnF/TnR respectively (Table S3). gDNA
was digested with HindIII, separated by agarose gel electrophoresis
and transferred to positively charged nylon membrane. Hybrid-
ization was performed overnight at 60uC and DIG detection was
performed according to the manufacturers’ guidelines (Roche).
BlaM translocation assay
CBU0077, CBU0635 and CBU1524 were introduced into the
SalI site of pJB-CAT-BlaM to create a BlaM fusion constructs
under the control of the CBU1169 promoter. These constructs
were electroporated into C. burnetii and individual clones isolated
after two passages with chloramphenicol selection. BlaM expres-
sion was confirmed by western blot with anti-BlaM (1:1000, QED
Bioscience Inc, San Diego, CA). Approximately 2610
4 HeLa cells
were seeded in black clear bottom 96 well trays (Corning
Incorporated, Corning NY). The next day monolayers were
infected with C. burnetii at the appropriate MOI and the infection
allowed to proceed until the desired time point. Cells were loaded
with the fluorescent substrate CCF4/AM, using the LiveBLAzer-
FRET B/G Loading Kit (Invitrogen) with 15 mM probenecid, in
the dark for 2 h at room temperature. Fluorescence, using an
excitation of 415 nm and emission at 460 nm and 535 nm, was
quantified using the Tecan M1000 plate reader. Following
background subtraction the ratio of 460 nm to 535 nm (blue:-
green) was calculated and expressed relative to uninfected cells.
For single cell assays, the infection and stain procedure was
similar. Cells were visualized by fluorescence microscopy using an
inverted Nikon Eclipse TE-2000 S microscope and a 206
objective. A total of 400 cells were counted in three independent
wells to determine the percent of cells that were BlaM positive.
Images were acquired, exported as TIFF files and labeled with
Adobe Illustrator.
C. burnetii infections
HeLa 229 and Vero cells were plated at a density of 5610
4 into
24 well trays in DMEM with 2%FBS. Axenically grown C. burnetii
strains were quantified by qPCR using dotA specific primers [3] to
provide an accurate MOI of 50. Following a 4 h infection period,
cells were washed once and incubated with fresh DMEM with 2%
FBS. Wells were collected for analysis 24 (Day 1), 72 (Day 3), 120
(Day 5) and 168 (Day 7) h after this initial time point. Cells were
either fixed with 4% paraformaldehyde for subsequent immuno-
fluorescent analysis or lysed by hypotonic lysis and collected for C.
burnetii quantification. Bacteria were pelleted from lysed cells,
gDNA extracted using the illustra bacteria genomicPrep Mini
Prep Kit (GE Healthcare) and genomic equivalents quantified by
qPCR. To quantify the proportion of cells intracellular after the
4 h infection period fixed cells were stained with mouse anti-C.
burnetii (1:5000) and Alexa Fluor 596 anti-mouse before secondary
fixation and permeablization. Samples were then stained with
rabbit anti-C. burnetii (1:10000) and Alexa Fluor 488 anti-rabbit.
The proportion of cell associated bacteria that were intracellular,
those stained green only, were quantified for at least 400 HeLa
cells per coverslip. Two coverslips per sample were quantified from
three independent experiments.
For the intracellular viability studies the infections with C.
burnetii were performed as described above. At the indicated time
points after infection the HeLa cells were extensively washed with
PBS to remove any remaining extracellular bacteria before
hypotonic lysis. The lysed cell material was added to 1 ml of
ACCM and then diluted 1:100 in ACCM. Genome equivalents in
the starting samples were determined by qPCR. The diluted
lysates in ACCM were incubated at 37uC, 5% CO2, 2.5% O2 for
seven days and qPCR was used to determine the amount of
replication that had occurred.
Supporting Information
Figure S1 Determining the ratio at which translocation of Cya-
RalF by L. pneumophila can be detected in the presence of
competing L. pneumophila that do not produce a Cya fusion protein
having a type IV secretion signal. L. pneumophila transformed with
pEC33 encoding Cya alone (pCya) or pEC33 encoding Cya-RalF
(pRalF) were mixed at ratios shown. Pools consisting of the
bacteria at the indicated ratios (x-axis) were assayed for
translocation of the Cya reporter following infection of CHO-
FccRII cells by measuring production of cAMP (y-axis). Data
indicate that Dot/Icm-dependent translocation of RalF remained
detectible in a mixed pool that contained 1 bacterial cell producing
Cya-RalF to 49 bacterial cells containing Cya alone. Experiments
were performed in triplicate and error bars represent standard
deviation.
(PDF)
Figure S2 Strategy for screening a C. burnetii library to identify
clones having a Dot/Icm-dependent translocation domain fused to
Cya. (A) C. burnetii gene fragments were ligated at random
downstream of the gene encoding Cya and the resulting plasmid
library was electroporated into L. pneumophila. Individual
L. pneumophila transformants were distributed into 24-well dishes to
establish pools containing an estimated 50 different plasmid clones.
Each pool was saved as a frozen stock, and also used to infect CHO
FccRII cells to determine whether the pool contained a potential
fusion between Cya and a C. burnetii Dot/Icm-dependent translo-
cation domain. The graph shows data from a screen conducted on
Genetic Analysis of the C. burnetii Dot/Icm System
PLoS Pathogens | www.plospathogens.org 15 May 2011 | Volume 7 | Issue 5 | e1002056pools of 50 clones. Four different pools (1–4) were identified that
were predicted to contain clones having a Cya fusion to a Dot/Icm
translocation domain based on cAMP values being 2.5-fold above
background.Foreverypositivepool,96singlecolonieswerearrayed
into a well in a 96-well plate. To identify single clones from a pool
that had activity in the translocation assay, the plate containing
clones from that pool was first screened by combining the 12 clones
from each row of the plate, and testing the combined pool of
12 clones from each row for translocation activity. For any row that
gave a positive signal in the translocation assay, the clones from the
12 different wells in that row were tested individually for
translocation activity. (B) Shown are data obtained using the
96-well plates containing clones arrayed from pools 1–4 in panel A.
An internal control for each assay was the analysis of the pool of
50 clones (grey bar). The black bars are data obtained for the pools
consisting of the 12 clones from a row on the indicated plate.
Highlighted are the rows from pool 1 predicted to contain positive
clones (A, B), rows from pool 2 predicted to contain positive clones
(C, D), and a row from pool 4 predicted to have a positive clone (E).
(C) Shown aredataobtained forthe individualclonesobtained from
each positive row identified in panel B. As the data indicate, a
positive clone that gave a very high translocation signal was
identified from each row. Plasmid DNA was isolated from the clone
in each positive well, and the fusion junction was sequenced to
determine the C. burnetii gene attached to the Cya reporter. Multiple
individual wells giving a positive signal were usually identified from
the 96-well plate arrayed for a positive pool, however, the
sequencing data for the clones isolated from those wells usually
revealed identicalfusionproteins,meaning that positivewellsfrom a
single pool typically identified siblings having the same plasmid.
There were no examples where two different effectors were
identified from a single pool.
(PDF)
Figure S3 Expression of Cya fusion proteins in L. pneumophila.
Immunoblot analysis of L. pneumophila cell lysates indicates equal
levels of protein production for the fusions Cya-CBU1780, Cya-
CBU1957 and Cya-CBU2064 compared to the control proteins
Cya alone and Cya-RalF. Translocation of these three Cya fusion
proteins was not detected.
(PDF)
Figure S4 Coxiella genes are transcribed during host cell
infection. RT-PCR analysis on bacterial RNA isolated from
persistently infected CHO-FccRII cells using primers specific for
the genes indicated. (A) Analysis of C. burnetii genes identified
initially using the Cya reporter screen. (B) Analysis of C. burnetii
genes encoding effectors identified based on homology or
proximity to other effectors. In both panels, icmS and icmW serve
as positive controls. Reactions were performed in the presence (+)
or absence (2) of reverse transcriptase to make certain that RNA
served as the template. Locations of DNA standards are shown on
the left in base pairs. Primer pairs were designed to amplify a
fragment of roughly 300 bp for each gene. Shown are the results
from one representative experiment out of two experiments in
which similar results were obtained.
(PDF)
Figure S5 C. burnetii effectors that display cytosolic localization
in mammalian cells. The indicated C. burnetii effector proteins
tagged at the amino terminus with a 36FLAG epitope were
produced in HeLa 229 cells. Fluorescence micrographs obtained
by anti-FLAG staining show diffuse cytosolic staining of each
effector protein, and no difference was observed when compared
to homologues encoded by the Dugway or G strains of C. burnetii.
(PDF)
Figure S6 The icmL::Tn mutant has no obvious defect in
replicating in defined medium or invading and surviving in
cultured host cells. (A) Ex vivo replication of C. burnetii NM (black
squares) and the isogenic icmL::Tn mutant (white squares) was
measured in ACCM. Samples were taken at the times indicated (x-
axis) and genome equivalents were determined by qPCR (y-axis).
The graph represents the mean 6 SD from three independent
experiments. (B) C. burnetii NM and the isogenic icmL::Tn mutant
were added to HeLa cells at a multiplicity of infection of 50 and
incubated for 4 h at 37uC. Cells were washed and fixed with 4%
paraformaldehyde. Before cells were permeabilized, extracellular
C. burnetii were stained with a mouse anti-C. burnetii antibody
(1:5000) and an Alexa Fluor 596-labeled anti-mouse secondary
antibody. After a second round of fixation, cells were permeabi-
lized and stained with a rabbit anti-C. burnetii antibody (1:10000)
and an Alexa Fluor 488-labeled anti-rabbit secondary antibody.
Cells were visualized by fluorescence microscopy and differential
staining of intracellular and extracellular bacteria was used to
determine the ratio of intracellular and extracellular C. burnetii by
counting bacteria associated with at least 400 HeLa cells on a
coverslip. Two coverslips were examined for each strain in three
independent experiments. Data are presented as the percent of
cell-associated C. burnetii that were intracellular (x-axis) for the NM
strain (grey bar) and the icmL::Tn mutant (white bar). Values are
the mean 6 SD for the three independent experiments. No
significant difference was observed for the internalization of the
NM strain compared to the icmL::Tn mutant. (C) HeLa cells
infected at a MOI of 50 were extensively washed and lysed at the
indicated times. The samples were diluted 1:100 in ACCM and
incubated for 7 days. The 1:100 dilutions showed signs of bacterial
replication for all samples, suggesting the presence of viable
bacteria in the samples obtained from infected host cells. C. burnetii
GE were calculated in the 1:00 dilutions after 7 days of incubation
and plotted as fold increase compared to the GE number obtained
for that dilution at the time of cell lysis. C. burnetii NM (black bars),
C. burnetii NM treated with 10 mg/ml chloramphenicol (grey bars)
and icmL::Tn (white bars) showed similar growth after extraction
from HeLa cells indicating the comparable viability of intracellular
bacteria. This experiment yielded similar results when conducted
for duplicate wells in three independent infections.
(PDF)
Figure S7 Expression of BlaM-effector fusion proteins in C.
burnetii. Immunoblot analysis of C. burnetii NM phase II and the
icmL::Tn mutant harboring pJB-CAT-BlaM (BlaM) and BlaM-
effector fusion constructs (BlaM-77, BlaM-0635 and BlaM-1524).
Probing equivalent amounts of these C. burnetii transformants with
anti-BlaM demonstrated expression of BlaM (29 kDa), BlaM-77
(60 kDa), BlaM-0635 (84 kDa) and BlaM-1524 (54 kDa). Impor-
tantly, expression of each reporter protein was comparable in C.
burnetii NM phase II and the icmL::Tn mutant.
(PDF)
Table S1 Cya fusions screened that were positive for protein
translocation. Indicated are the proteins identified in the screen for
C. burnetii proteins with a Dot/Icm-dependent translocation signal.
Shown are the proteins identified, the number of times each
protein was identified in the screen, and the position in the
location of the Cya fusion junction in the predicted protein
product.
(DOC)
Table S2 Additional C. burnetii genes examined for Dot/Icm-
dependent translocation. Indicated are the C. burnetii genes with
homology or proximity to the genes encoding proteins identified in
the screen for Dot/Icm-dependent translocation signals. The
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translocation, and the translocation results are given.
(DOC)
Table S3 Primers used in this study. Listed are the sequences of
primers used in this study to create plasmids encoding the C.
burnetii effectors, to test for their expression, and to map the
location of transposon insertions. Restriction sites in primers that
were used to ligate the resulting PCR products into plasmids are
underlined.
(DOC)
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